Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.720
+0.120 (4.62%)
At close: Nov 4, 2026, 4:00 PM EST
2.715
-0.006 (-0.20%)
After-hours: Nov 4, 2026, 7:59 PM EST
Editas Medicine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 11.89 | 2.83 | 24.74 | 7.54 | 3.58 | 4.66 | 30.6 | 0.06 | 0.51 | 1.14 | 60.05 | 5.34 | 2.89 | 9.85 | 6.54 | 0.04 | 6.36 | 6.77 | 12.47 | 6.2 | |
Revenue Growth (YoY) | 232.31% | -39.22% | -19.16% | 12265.57% | 597.47% | 310.40% | -49.04% | -98.86% | -82.23% | -88.48% | 818.74% | 12604.76% | -54.62% | 45.49% | -47.58% | -99.32% | 1578.63% | 4.18% | 9.20% | -90.14% |
Cost of Revenue | 20.18 | 17.6 | 27.4 | 19.78 | 16.18 | 26.59 | 48.61 | 47.64 | 54.21 | 48.79 | 69.56 | 40.51 | 29.78 | 37.8 | 52 | 41.33 | 43.66 | 37.98 | 37.55 | 29.27 |
Gross Profit | -8.29 | -14.77 | -2.66 | -12.23 | -12.6 | -21.94 | -18.01 | -47.58 | -53.7 | -47.65 | -9.51 | -35.18 | -26.89 | -27.95 | -45.46 | -41.28 | -37.3 | -31.21 | -25.08 | -23.07 |
Selling, General & Admin | 11.6 | 10.23 | 11.35 | 12.32 | 12.86 | 13.38 | 16.35 | 18.09 | 18.21 | 19.34 | 14.46 | 14.99 | 17.2 | 23.01 | 17.98 | 16.24 | 16.94 | 19.55 | 16.53 | 16.19 |
Operating Expenses | 11.6 | 10.23 | 11.35 | 12.32 | 12.86 | 13.38 | 16.35 | 18.09 | 18.21 | 19.34 | 14.46 | 14.99 | 17.2 | 23.01 | 17.98 | 16.24 | 16.94 | 19.55 | 16.53 | 16.19 |
Operating Income | -19.89 | -25 | -14.02 | -24.55 | -25.46 | -35.31 | -34.36 | -65.67 | -71.9 | -66.99 | -23.96 | -50.16 | -44.09 | -50.96 | -63.45 | -57.52 | -54.23 | -50.75 | -41.61 | -39.25 |
Interest Expense | -1.06 | -1.07 | - | -2.4 | -2.02 | -2.22 | -2.19 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest & Investment Income | 1.37 | 1.21 | 2.14 | 1.83 | 2.09 | 2.72 | 3.39 | 3.53 | 4.3 | 5.04 | 5.1 | 5.14 | 3.81 | 3.51 | 2.71 | 1.79 | 0.55 | 0.47 | 1.91 | 0.15 |
Other Non Operating Income (Expenses) | 0.02 | -0.11 | 2.18 | -0 | -1.76 | -1.01 | - | -0.01 | -0 | 0.01 | 1.59 | - | -0.01 | -1.58 | -0 | 0 | 0.24 | -0.23 | -0.04 | 0.02 |
EBT Excluding Unusual Items | -19.57 | -24.98 | -9.69 | -25.12 | -27.15 | -35.82 | -33.16 | -62.14 | -67.61 | -61.95 | -17.27 | -45.02 | -40.29 | -49.04 | -60.74 | -55.73 | -53.45 | -50.52 | -39.74 | -39.08 |
Merger & Restructuring Charges | 1.34 | - | 10.02 | - | -26.08 | -40.85 | -12.23 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gain (Loss) on Sale of Investments | - | - | -2.19 | - | - | 0.58 | -0 | - | - | - | -1.6 | - | - | - | - | - | - | - | -1.7 | - |
Gain (Loss) on Sale of Assets | - | - | -3.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -18.23 | -24.98 | -5.62 | -25.12 | -53.24 | -76.09 | -45.4 | -62.14 | -67.61 | -61.95 | -18.87 | -45.02 | -40.29 | -49.04 | -60.74 | -55.73 | -53.45 | -50.52 | -41.44 | -39.08 |
Net Income | -18.23 | -24.98 | -5.62 | -25.12 | -53.24 | -76.09 | -45.4 | -62.14 | -67.61 | -61.95 | -18.87 | -45.02 | -40.29 | -49.04 | -60.74 | -55.73 | -53.45 | -50.52 | -41.44 | -39.08 |
Net Income to Common | -18.23 | -24.98 | -5.62 | -25.12 | -53.24 | -76.09 | -45.4 | -62.14 | -67.61 | -61.95 | -18.87 | -45.02 | -40.29 | -49.04 | -60.74 | -55.73 | -53.45 | -50.52 | -41.44 | -39.08 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 119 | 98 | 97 | 90 | 84 | 83 | 83 | 82 | 82 | 82 | 82 | 82 | 71 | 69 | 69 | 69 | 69 | 68 | 68 | 68 |
Shares Outstanding (Diluted) | 119 | 98 | 97 | 90 | 84 | 83 | 83 | 82 | 82 | 82 | 82 | 82 | 71 | 69 | 69 | 69 | 69 | 68 | 68 | 68 |
Shares Change (YoY) | 41.32% | 17.85% | 17.72% | 9.22% | 2.55% | 1.36% | 1.11% | 1.03% | 15.32% | 18.88% | 18.78% | 18.79% | 3.99% | 0.64% | 0.64% | 0.76% | 1.13% | 3.78% | 9.76% | 8.81% |
EPS (Basic) | -0.15 | -0.26 | -0.06 | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 | -0.23 | -0.55 | -0.56 | -0.71 | -0.88 | -0.81 | -0.78 | -0.74 | -0.61 | -0.57 |
EPS (Diluted) | -0.15 | -0.26 | -0.06 | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 | -0.23 | -0.55 | -0.56 | -0.71 | -0.88 | -0.81 | -0.78 | -0.74 | -0.61 | -0.57 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -29.67 | -23.15 | -36.45 | -31.28 | -50.21 | -47.91 | -51.3 | -55.51 | -60.56 | -51.74 | -23.55 | -35.7 | -40.04 | -37.61 | -42.9 | -48.62 | -38.48 | -51.48 | -37.43 | -43.13 |
Free Cash Flow Per Share | -0.25 | -0.24 | -0.38 | -0.35 | -0.59 | -0.58 | -0.62 | -0.67 | -0.74 | -0.63 | -0.29 | -0.44 | -0.56 | -0.55 | -0.62 | -0.71 | -0.56 | -0.75 | -0.55 | -0.63 |
Gross Margin | -69.72% | - | -10.76% | -162.16% | - | - | -58.84% | - | - | - | -15.83% | - | - | -283.76% | - | - | - | - | -201.17% | - |
Operating Margin | -167.31% | -883.19% | -56.65% | -325.44% | -711.63% | -758.05% | -112.28% | -107649.18% | -14016.18% | -5902.29% | -39.90% | -940.09% | -1527.33% | -517.32% | -970.72% | -136952.38% | -852.47% | -749.52% | -333.71% | -633.42% |
Profit Margin | -153.32% | -882.44% | -22.71% | -332.98% | -1487.84% | -1633.49% | -148.33% | -101870.49% | -13178.75% | -5458.15% | -31.43% | -843.68% | -1395.57% | -497.78% | -929.28% | -132680.95% | -840.19% | -746.05% | -332.31% | -630.66% |
Free Cash Flow Margin | -249.57% | -817.84% | -147.31% | -414.64% | -1403.35% | -1028.62% | -167.63% | -90998.36% | -11804.29% | -4558.85% | -39.21% | -669.00% | -1387.05% | -381.77% | -656.32% | -115757.14% | -604.79% | -760.23% | -300.16% | -695.97% |
EBITDA | -19.48 | -24.52 | -13.21 | -23.83 | -23.63 | -33.39 | -31.19 | -64.07 | -70.48 | -65.58 | -22.5 | -48.65 | -42.55 | -49.42 | -61.87 | -55.92 | -52.64 | -49.19 | -40.1 | -38.06 |
EBITDA Margin | -163.81% | - | -53.40% | - | - | - | -101.92% | - | - | - | -37.46% | - | - | - | - | - | - | - | - | - |
D&A For EBITDA | 0.42 | 0.48 | 0.81 | 0.72 | 1.83 | 1.92 | 3.17 | 1.6 | 1.42 | 1.41 | 1.47 | 1.51 | 1.54 | 1.54 | 1.58 | 1.6 | 1.6 | 1.56 | 1.51 | 1.19 |
EBIT | -19.89 | -25 | -14.02 | -24.55 | -25.46 | -35.31 | -34.36 | -65.67 | -71.9 | -66.99 | -23.96 | -50.16 | -44.09 | -50.96 | -63.45 | -57.52 | -54.23 | -50.75 | -41.61 | -39.25 |
EBIT Margin | -167.31% | - | -56.65% | - | - | - | -112.28% | - | - | - | -39.90% | - | - | - | - | - | - | - | - | - |